Le Lézard
Classified in: Health
Subjects: EXE, RCL, PSF

Advisory - Important safety information for people with diabetes using NovoPen Echo or NovoPen 5


OTTAWA, July 25, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that Novo Nordisk A/S has updated a voluntary recall of insulin cartridge holders used in certain lots of its NovoPen Echo and NovoPen 5 insulin pens.  The company detected that the cartridge holders may crack or break if exposed to certain chemicals, such as some cleaning agents.

Affected Products
NovoPen Echo:

Device Lot Number

Package Lot Number

DUG2373

DVG1368

EVG2915

EVG3010

EVG4252

EVG5699

EVG5946

EVG5963

FVG7337

FVG7561

FVG8131

FVG8132

FVG8212

FVG8414

FVG8994

FVG8997

DUG2373-5

DVG1368-B

EVG2915-7

EVG3010-2

EVG4252-6

EVG5699-6

EVG5946-7

EVG5963-1

FVG7337-2

FVG7561-1

FVG8131-5

FVG8132-6

FVG8212-1

FVG8414-9

FVG8994-1

FVG8997-1



NovoPen 5:

Device Lot Number

Package Lot Number

EVG5564

EVG3337

EVG5564

EVG0915

FVG7336

FVG7377

EVG6240
EVG6241
FVG6867
FVG6868
FVG7469
FVG7568

 

Background
Novo Nordisk A/S has advised that using a device with a cracked or broken cartridge holder can result in a smaller dose of insulin than expected, which may lead to hyperglycemia (high blood sugar). According to Novo Nordisk A/S, the risk of experiencing high blood sugar with the use of a device with an affected cartridge holder is evaluated to be less than 0.1 per cent. This means that less than one in 1,000 patients with an affected cartridge holder will experience high blood sugar.

Warning symptoms of high blood sugar include: flushed, dry skin, sleepiness or tiredness, dry mouth, breath that smells fruity or like acetone (nail polish remover), frequent urination, feeling thirsty, loss of appetite, nausea, and vomiting. It is possible that high blood sugar may only be seen by measuring blood sugar levels, and may not display any physical signs.

Novo Nordisk A/S has confirmed that the cartridge holder issue does not affect NovoPen Echo or NovoPen 5 devices with a lot number that is not mentioned above.

What consumers should do

 

Related Links

Recall - NovoPen 5 and NovoPen Echo

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

 

 Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: